JW Pharmaceutical Corporation (KRX:001060)
South Korea
· Delayed Price · Currency is KRW 22,400
+500 (2.28%)
At close: Mar 24, 2025, 3:30 PM KST
JW Pharmaceutical Revenue
In the year 2024, JW Pharmaceutical had annual revenue of 719.38B KRW, down -3.89%. JW Pharmaceutical had revenue of 187.85B in the quarter ending December 31, 2024, a decrease of -8.37%.
Revenue
719.38B
Revenue Growth
-3.89%
P/S Ratio
0.68
Revenue / Employee
676.11M
Employees
1,064
Market Cap
494.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 719.38B | -29.15B | -3.89% |
| Dec 31, 2023 | 748.53B | 64.18B | 9.38% |
| Dec 31, 2022 | 684.35B | 77.77B | 12.82% |
| Dec 31, 2021 | 606.58B | 59.25B | 10.83% |
| Dec 31, 2020 | 547.34B | 36.00B | 7.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |